Medical Advocates
Pneumocystis jirovecii (carinii)
  Clinical Management

 General Management Challenges
 HIV-Associated Pneumonia
 Non-HIV-Associated Pneumonia
 Drugs 




 
P. Pneumonia Main Page Main New/Newsworthy  Home Page     
Last Update:  September 12, 2016
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Management Challenges
       
          Journal Papers, Abstracts, and Commentaries
 
 
tECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.
Maertens J, Cesaro S, Maschmeyer G,  et al
J Antimicrob Chemother. 2016 Sep;71(9):2397-404.
 Abstract

ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.
Alanio A, Hauser PM, Lagrou K, et al
J Antimicrob Chemother. 2016 Sep;71(9):2386-96.
Abstract

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.
Cordonnier C, Cesaro S, Maschmeyer G, et  al
 lJ Antimicrob Chemother. 2016 Sep;71(9):2379-85
 Abstract

 

Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014.
Cooley L, Dendle C, Wolf J,  et al
 Intern Med J. 2014 Dec;44(12b):1350-63.
Abstract

Update on the diagnosis and treatment of Pneumocystis pneumonia.
Carmona EM, Limper AH.T
her Adv Respir Dis. 2010 Aug 24.
 Abstract

HIV-Associated Pneumocystis Pneumonia
       

          Journal Papers, Abstracts, and Commentaries
 
 
Discontinuing Pneumocystis jirovecii Pneumonia Prophylaxis in HIV-Infected Patients With a CD4 Cell Count <200 cells/mm3.
Sidhu VK, Foisy MM, Hughes CA.
Ann Pharmacother. 2015 Sep 10.
Abstract

The Use of ECMO in HIV/AIDS with Pneumocystis jirovecii Pneumonia: A Case Report and Review of the Literature.
Cawcutt K, Gallo De Moraes A, et al
ASAIO J. 2014 September/October;60(5):606-608..
 Abstract

Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study.
Helweg-Larsen J, Benfield T, Atzori C, Miller RF.|
J Antimicrob Chemother. 2009 Dec;64(6):1282-90
 Abstract

Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study.
Helweg-Larsen J, Benfield T, Atzori C, Miller RF.
 J Antimicrob Chemother. 2009 Dec;64(6):1282-90
 Abstract

Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.
Su YS, Lu JJ, Perng CL, Chang FY.
 J Microbiol Immunol Infect. 2008 Dec;41(6):478-82.
 Abstract

Second-Line Salvage Treatment of AIDS-Associated Pneumocystis jirovecii Pneumonia: A Case Series and Systematic Review.
Benfield T, Atzori C, Miller RF, Helweg-Larsen J.
J Acquir Immune Defic Syndr. 2008 Mar 20
 Abstract
 
Non-HIV-Associated Pneumocystis Pneumonia
       

          Journal Papers, Abstracts, and Commentaries

 
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients.
Maschmeyer G, Helweg-Larsen J, Pagano L, et al
J Antimicrob Chemother. 2016 Sep;71(9):2405-
 Abstract

Pneumocystis Pneumonia in Patients Treated With Long-Term Steroid Therapy for Symptom Palliation: A Neglected Infection in Palliative Care.
Yamaguchi T, Nagai Y, Morita T, et al
Am J Hosp Palliat Care.2013 Sep 30.
Abstract

Therapeutic Effect of Direct Hemoperfusion with a Polymyxin B-Immobilized Fiber Column in the Treatment of HIV-Negative Severe Pneumocystis Pneumonia.
Tachikawa R, Tomii K, Murase K, et al
Respiration. 2010 Jun 9
 Abstract
 
 

P. Pneumonia Main Page Main New/Newsworthy  Home Page     

Pneumocystis jirovecii (carinii)
Clinical Management